Mid-term follow-up of pulmonary valve bioprostheses in adults with congenital heart disease

Sadeghpour, Anita; Javani, Bahareh; Peighambari, Mohammadmehdi; Kyavar, Majid; Khajali, Zahra

doi:10.5152/akd.2012.128

Cited by 4 publications

(2 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thrombolysis is a Class I AHA and a Class IIa European Society of Cardiology (ESC) guideline recommendation for left-sided thrombosis [11,12,27,28]. Our study showed a high efficacy rate for thrombolytic therapy (>80%) for PVT, [12,17,24,[29][30][31][32][33] with the efficiency boosted further by longer durations of thrombolytic drug administration. For streptokinase, the response rate to thrombolytic was 30% on the first day of infusion and it reached 80% on the third day.…”

Section: Discussionmentioning

confidence: 75%

Mechanical Pulmonary Valve Thrombosis: Recurrence and Response to Thrombolytic Therapy

Hosseini¹

2021

JOCCT

View full text Add to dashboard Cite

Prosthetic valve thrombosis (PVT) is a serious complication in the left-sided heart valve. However, in the right-side position, this complication may be completely asymptomatic or accompanied by only a few symptoms. Research on the prevalence of thrombosis in right-sided valves is still insufficient. We sought to retrospectively report our center’s experience concerning PVT and its management outcomes.

show abstract

Section: Discussionmentioning

confidence: 75%

Mechanical Pulmonary Valve Thrombosis: Recurrence and Response to Thrombolytic Therapy

Hosseini¹

2021

JOCCT

View full text Add to dashboard Cite

show abstract

“… 11 - 13 Nonetheless, both of these tissue valves are liable to deteriorate overtime, necessitating (potentiallymultiple) reoperations with concomitant morbidityand mortality. 14 , 15 …”

Section: Introductionmentioning

confidence: 99%

Mid-Term Outcome of Mechanical Pulmonary Valve Prostheses: The Importance of Anticoagulation

Sadeghpour¹,

Kyavar²,

Javani³

et al. 2014

J Cardiovasc Thorac Res

Self Cite

View full text Add to dashboard Cite

Introduction: Pulmonary valve replacement (PVR) is being performed more commonly late after the correction of tetralogy of Fallot. Most valves are replaced with an allograft or xenograft, although reoperations are a common theme. Mechanical prostheses have a less favorable reputation due to the necessity of lifelong anticoagulation therapy and higher risk of thrombosis, but they are also less likely to require reoperation. There is a paucity of data on the use of prosthetic valves in the pulmonary position. We report the midterm outcomes of 38 cases of PVR with mechanical prostheses. Methods: One hundred twenty two patients who underwent PVR were studied. Thirty-eight patients, mean age 25 ± 8.4 years underwent PVR with mechanical prostheses based on the right ventricular function and the preferences of the patients and physicians. Median age of prosthesis was 1 year (range 3 months to 5 years). Results: Seven (18%) patients had malfunctioning pulmonary prostheses and two patients underwent redo PVR. Mean International Normalized Ratio (INR) in these seven patients was 2.1±0.8. Fibrinolytic therapy was tried and five of them responded to it well. There was no significant association between the severity of right ventricular dysfunction, patient’s age, prostheses valve size and age of the prosthesis in the patients with prosthesis malfunction. Conclusion: PVR with mechanical prostheses can be performed with promising midterm outcomes. Thrombosis on mechanical pulmonary valve prostheses remains a serious complication, but most prosthesis malfunction respond to fibrinolytic therapy, underscoring the need for adequate anticoagulation therapy.

show abstract

Tetralogy of Fallot

Sadeghpour

Alizadehasl

Mahdavi³

2014

Comprehensive Approach to Adult Congenital Heart Disease

View full text Add to dashboard Cite

Mid-term follow-up of pulmonary valve bioprostheses in adults with congenital heart disease

Cited by 4 publications

References 26 publications

Mechanical Pulmonary Valve Thrombosis: Recurrence and Response to Thrombolytic Therapy

Mechanical Pulmonary Valve Thrombosis: Recurrence and Response to Thrombolytic Therapy

Mid-Term Outcome of Mechanical Pulmonary Valve Prostheses: The Importance of Anticoagulation

Tetralogy of Fallot

Contact Info

Product

Resources

About